 |
PowderJect is a rapidly growing pharmaceutical company
headquartered in Oxford, UK, with facilities located in Europe and
the US. With a range of products sold under its Evans Vaccines and
SBL Vaccine brands, PowderJect is one of the world's largest
vaccines companies. PowderJect's portfolio of products includes
vaccines for influenza, yellow fever, travel diarrhoea, cholera,
tuberculosis, polio, tetanus and hepatitis B. The company's
world-class biologics manufacturing facilities are amongst the
largest in Europe, and are approved by both the US and European
regulatory authorities. |
|
PowderJect Pharmaceuticals
Plc, Oxford |
PowderJect's technology focus is on the powder injection of medicines,
a field in which it leads the world. The company is developing a broad
range of vaccines based upon this proprietary delivery technology.
PowderJect is also the world leader in the field of DNA vaccines, a
revolutionary new method of vaccination that offers the potential to
protect against and treat diseases such as hepatitis B and HIV.
|
Many of the innovative vaccines that PowderJect is developing
incorporate its unique delivery technology, powder injection. This
patented technology offers a unique range of benefits. By delivering
vaccines into the outer layer of skin in a simple-to-use-device, the
PowderJect® system offers patients needle-free medicines.
Powder-form medicines also offer pharmaco-economic advantages:
PowderJect products avoid the need for costly cold chain required
for many vaccines. However, the most important benefit offered by
powder injection delivering to the correct layer of the skin, is
the |
|
|
Evans Vaccines Ltd, Liverpool
|
| ability to improve the performance of vaccines.
Research shows that by targeting the skin's epidermis, powder
injection can greatly increase the size and quality of the immune
response achieved by both conventional and DNA vaccines.
|
As a fully integrated vaccines company with significant research,
development, manufacturing, marketing and distribution capabilities,
PowderJect has built the foundations on which to grow its business
rapidly.
|
PowderJect understands that exceptional people create exceptional
companies which is why we hire talented individuals supportive of
corporate culture, then support them in realizing their personal
potential through achievement of our corporate goals.
Our Research & Development group can offer exciting career
opportunities in the following areas: |
 |
- Device Engineering
- Formulation
- Analytical
- Clinical R&D
- Support function
|
- Preclinical R&D
- Programme Management
- Medical
- Biological Systems
| |
|
In addition to excellent career opportunities and exciting
advancement potential, PowderJect also provides exceptional
compensation and benefits including: |
| |
- Share Options
- Pension Scheme
- Private Medical Insurance
- Permanent Health Insurance
- Life Assurance
- 25 days Annual Leave
| |
|